ISTH 2022 Congress
Venous Thromboembolism » VTE Treatment
Theme Navigation
- ISTH 2022 Congress
- Venous Thromboembolism
- VTE Treatment
- Venous Thromboembolism
-
Abstract Number: VPB0467
Factors influencing the decision making on thrombolytic therapy in normotensive patients with pulmonary embolism: data from SIRENA registry
-
Abstract Number: PB0465
Feasibility Study of Patient Self-Management of Warfarin using the Fearon Algorithm
-
Abstract Number: OC 62.4
FVIII and D-dimer values at trough and peak concentrations of direct oral anticoagulants: important considerations for using these tests in assissting clinical decision for risk stratification scheme
-
Abstract Number: PB0456
Inferior vena cava filter in a tertiary Hospital of Barcelona: a descriptive study of 185 cases.
-
Abstract Number: VPB0468
Levels Of Heparin Induced Anti-PF4 Antibodies and Endogenous Glycosaminoglycans and Their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients.
-
Abstract Number: OC 14.2
Long-term outcomes of superficial vein thrombosis in daily practice: 12-month data from the INSIGHTS-SVT study
-
Abstract Number: VPB0470
Long-term results of tinzaparin for the treatment of superficial vein thrombosis of the lower limbs.
-
Abstract Number: OC 34.4
Long-Term Risk of Clinically Relevant Non-Major Bleeding During Extended Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-Analysis
-
Abstract Number: PB0455
Low molecular weight heparin beyond 12 months in patients with cancer associated thrombosis. CAT-LONG study.
-
Abstract Number: OC 34.3
Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: a score to identify high risk patients
-
Abstract Number: OC 23.1
Management of Patients with Unprovoked Venous Thromboembolism and a Low Risk of Recurrence with the Vienna Prediction Model: A Prospective Cohort Study
-
Abstract Number: PB0448
Median serum trough concentration of apixaban in pulmonary embolism patients after one month of therapy
-
Abstract Number: PB0441
No pharmacological effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in patients with breast cancer: the PHIX-IT study
-
Abstract Number: PB0463
Outcomes in clinical studies of interventions for venous thromboembolism in non-pregnant adults: A scoping review
-
Abstract Number: PB0461
Patient outcomes of catheter directed thrombolysis for upper extremity deep vein thrombosis
-
Abstract Number: PB0464
Peri-operative management of anticoagulation and bleeding in patients undergoing Catheter Directed Thrombolysis for acute iliofemoral Deep Vein Thrombosis
-
Abstract Number: OC 62.2
Pharmacokinetics of direct oral anticoagulants after bariatric surgery: A retrospective cohort study
-
Abstract Number: PB0466
Physician practice behaviors surrounding dose-reduction of direct oral anticoagulants for the extended phase treatment of venous thromboembolism
-
Abstract Number: VPB0469
Pulmonary cement embolism after kyphoplasty: Clinical and Laboratory aspects of pro-coagulant effects
-
Abstract Number: PB0453
Real-world Use of Andexanet Alfa for Anti-Xa Inhibitor Reversal: A Case Series